KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Current Taxes (2018 - 2025)

Historic Current Taxes for BioNTech SE (BNTX) over the last 7 years, with Q3 2025 value amounting to $7.4 million.

  • BioNTech SE's Current Taxes fell 9815.56% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year decrease of 9815.56%. This contributed to the annual value of $4.8 million for FY2024, which is 9914.95% down from last year.
  • BioNTech SE's Current Taxes amounted to $7.4 million in Q3 2025, which was down 9815.56% from $4.2 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Current Taxes ranged from a high of $1.8 billion in Q1 2022 and a low of $4.2 million during Q2 2025
  • Its 5-year average for Current Taxes is $661.7 million, with a median of $565.4 million in 2023.
  • In the last 5 years, BioNTech SE's Current Taxes skyrocketed by 20344.31% in 2022 and then crashed by 9914.95% in 2024.
  • BioNTech SE's Current Taxes (Quarter) stood at $1.8 billion in 2021, then crashed by 66.13% to $608.0 million in 2022, then decreased by 7.0% to $565.4 million in 2023, then plummeted by 99.15% to $4.8 million in 2024, then soared by 53.16% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, $4.2 million for Q2 2025, and $5.7 million during Q1 2025.